Nanoparticles in tuberculosis diagnosis, treatment and prevention: A hope for future

Digest Journal of Nanomaterials and Biostructures

Volumn 4, Issue 2, 2009, Pages 309-312

  Mathuria, Jitendra Prasad ^a  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Drug delivery; Nanoparticles; Tuberculosis treatment

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 70249116461     PISSN: None     EISSN: 18423582     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. C. Dye, S. Scheele, P. Dolin, V. Pathania, M. C. Raviglione. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282, 677-686(1999).
2. WHO. 2008. Global Tuberculosis Control surveillance, planning, financing. http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf (Accessed on 30th Nov. 2008).
3. C. M. Donald. Nanotechnology and Developing Countries Part 1: What Possibilities? http://www.azonano.com/details.asp?ArticleID=1428 (Accessed on 13th March. 2009)
4. D. Prabakaran, P. Singh, K. S. Jaganathan, S. P. Vyas. J. Contr Rel 95, 239 (2004).
5. R. Falk, T. W. Randolph, J. D. Meyer, R. M. Kelly, M. C. Manning. J. Contr Rel 44, 77 (1997).
6. S. Gelperina, K. Kisich, D. Michael. Iseman, H. Leonid. Am J. Respir Crit Care Med 172,1487 (2005).
7. R. Pandey, A. Zahoor, S. Sharma, G. K. Khuller. Tuberculosis (Edinb 83, 373 (2003).
8. C. Schmidt, R. Bodmeier, J Control Release 57,115 (1999).
9. S. Sharma, G. K. Khuller, J. of Antimicrob Chemother 54,761 (2004).
10. O. Kayser, C. Olbrich, S. L. Croft, A. F. Kiderlen. Parasitol Res 90, S63 (2003).
11. G. K. Khuller, J. of Antimicrob Chemother 54,266 (2004).
12. C. M. Johnson, R. Pandey, S. Sharma, G. K. Khuller, R. J. Basaraba, I. M. Orme, A. J. Lenaerts. Oral Therapy Using Nanoparticle-Encapsulated Antituberculosis Drugs in Guinea Pigs Infected with Mycobacterium tuberculosis. Antimicrob Chemother, Oct. 2005, p. 49(10), 4335 (2005).